ConductScience.org, home

Paper26418745

FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase.

Guan J and 12 others. Elife, 2015. Cited by 117 papers, by iCite.

Cite this record

ConductScience Library. FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase. Papers, record 26418745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26418745

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase.
PubMed
Journal
Elife
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
117
iCite
Relative citation ratio, by iCite
3.36
iCite
Revised in PubMed
2020-11-13
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guan JJikui
2Umapathy GGanesh
3Yamazaki YYasuo
4Wolfstetter GGeorg
5Mendoza PPatricia
6Pfeifer KKathrin
7Mohammed AAteequrrahman
8Hugosson FFredrik
9Zhang HHongbing
10Hsu AWAmy W
11Halenbeck RRobert
12Hallberg BBengt
13Palmer RHRuth Hhttps://orcid.org/0000-0002-2735-8470

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CytokinesMajor topic
Enzyme ActivationMajor topic
Receptor Protein-Tyrosine KinasesMajor topic
Anaplastic Lymphoma Kinase
Cell Line
Humans
Molecular Sequence Data
Protein Binding
Sequence Analysis, DNA

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112062106HEN-1, a secretory protein with an LDL receptor motif, regulates sensory integration and learning in Caenorhabditis elegans.Cell2002https://conductscience.org/library/papers/12062106PubMed
28223268Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.Development1993https://conductscience.org/library/papers/8223268PubMed
325605972Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK.Sci Signal2015https://conductscience.org/library/papers/25605972PubMed
418923524Oncogenic mutations of ALK kinase in neuroblastoma.Nature2008https://conductscience.org/library/papers/18923524PubMed
517285636The ligand Jelly Belly (Jeb) activates the Drosophila Alk RTK to drive PC12 cell differentiation, but is unable to activate the mouse ALK RTK.J Exp Zool B Mol Dev Evol2007https://conductscience.org/library/papers/17285636PubMed
615886198Activation and inhibition of anaplastic lymphoma kinase receptor tyrosine kinase by monoclonal antibodies and absence of agonist activity of pleiotrophin.J Biol Chem2005https://conductscience.org/library/papers/15886198PubMed
725955180Targeted Disruption of ALK Reveals a Potential Role in Hypogonadotropic Hypogonadism.PLoS One2015https://conductscience.org/library/papers/25955180PubMed
825331893Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/25331893PubMed
923104988Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma.Dis Model Mech2013https://conductscience.org/library/papers/23104988PubMed
1025351247The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma.Sci Signal2014https://conductscience.org/library/papers/25351247PubMed
1120190816Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells.Oncogene2010https://conductscience.org/library/papers/20190816PubMed
1222079349Anaplastic lymphoma kinase and leukocyte tyrosine kinase: functions and genetic interactions in learning, memory and adult neurogenesis.Pharmacol Biochem Behav2012https://conductscience.org/library/papers/22079349PubMed
1317586306Neuroblastoma.Lancet2007https://conductscience.org/library/papers/17586306PubMed
1421804922The neuroblastoma ALK(I1250T) mutation is a kinase-dead RTK in vitro and in vivo.Transl Oncol2011https://conductscience.org/library/papers/21804922PubMed
1512122009Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.J Biol Chem2002https://conductscience.org/library/papers/12122009PubMed
1617904822In contrast to agonist monoclonal antibodies, both C-terminal truncated form and full length form of Pleiotrophin failed to activate vertebrate ALK (anaplastic lymphoma kinase)?Cell Signal2007https://conductscience.org/library/papers/17904822PubMed
179174053ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)Oncogene1997https://conductscience.org/library/papers/9174053PubMed
1815226403ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth.J Cell Sci2004https://conductscience.org/library/papers/15226403PubMed
1918923525Activating mutations in ALK provide a therapeutic target in neuroblastoma.Nature2008https://conductscience.org/library/papers/18923525PubMed
2016880530Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.Mol Cell Biol2006https://conductscience.org/library/papers/16880530PubMed

See all 34 referencesDownload CSV of references

Cited by94

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 117 citations.

PMIDTitleJournalYearIn PapersSource
42803850ALK ATI in solid tumours: biological evidence, diagnostic challenges, and clinical relevance. a narrative review.Mol Biol Rep2026https://conductscience.org/library/papers/42803850PubMed
42616237Three decades of anaplastic lymphoma kinase: from physiological roles to cancer and immune evasion.Cancer Metastasis Rev2026https://conductscience.org/library/papers/42616237PubMed
41856795Alk-Fam150b (augmentor α) expression in the paraventricular nucleus of the mouse hypothalamus at molecular resolution, and its sensitivity to acute stress.J Neuroendocrinol2026https://conductscience.org/library/papers/41856795PubMed
41798535Anaplastic Lymphoma Kinase (ALK)-Positive Large B-cell Lymphoma in Children: A Case Report and Review of Literature.Cureus2026https://conductscience.org/library/papers/41798535PubMed
41771741Ribosomal Profiling of the Geniculate Ganglion Identifies the Receptor ALK as Critical for the Development and Maintenance of Oral Sensory Neurons.J Neurosci2026https://conductscience.org/library/papers/41771741PubMed
41670693Breaking resistance barriers: ensartinib as a milestone in anaplastic lymphoma kinase-driven non-small cell lung cancer therapy.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41670693PubMed
40382638AlkTango reveals a role for Jeb/Alk signaling in the Drosophila heart.Cell Commun Signal2025https://conductscience.org/library/papers/40382638PubMed
40208865Reanalysis of cryo-EM data reveals ALK-cytokine assemblies with both 2:1 and 2:2 stoichiometries.PLoS Biol2025https://conductscience.org/library/papers/40208865PubMed
40055571ALK in cancer: from function to therapeutic targeting.Nat Rev Cancer2025https://conductscience.org/library/papers/40055571PubMed
39138146Therapeutic advances of targeting receptor tyrosine kinases in cancer.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39138146PubMed
38948020Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment.Oncol Res2024https://conductscience.org/library/papers/38948020PubMed
38927035Lysophosphatidic Acid Stimulates Mitogenic Activity and Signaling in Human Neuroblastoma Cells through a Crosstalk with Anaplastic Lymphoma Kinase.Biomolecules2024https://conductscience.org/library/papers/38927035PubMed
38482965Molecular pathological approach to cancer epigenomics and its clinical application.Pathol Int2024https://conductscience.org/library/papers/38482965PubMed
38424421A Review on Anaplastic Lymphoma Kinase (ALK) Rearrangements and Mutations: Implications for Gastric Carcinogenesis and Target Therapy.Curr Protein Pept Sci2024https://conductscience.org/library/papers/38424421PubMed
38397899Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions.Biomedicines2024https://conductscience.org/library/papers/38397899PubMed
38264745ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib.Front Oncol2023https://conductscience.org/library/papers/38264745PubMed
38039964ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells.Cancer Cell2023https://conductscience.org/library/papers/38039964PubMed
37892172Multifaceted Roles of ALK Family Receptors and Augmentor Ligands in Health and Disease: A Comprehensive Review.Biomolecules2023https://conductscience.org/library/papers/37892172PubMed
37773318ALK fusions in the pan-cancer setting: another tumor-agnostic target?NPJ Precis Oncol2023https://conductscience.org/library/papers/37773318PubMed
37686528IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway.Cancers (Basel)2023https://conductscience.org/library/papers/37686528PubMed

See all 94 cited byDownload CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26418745

GET https://conductscience.org/api/papers/v1/26418745/references?page=2